Speakers

Andrew Billin

Senior Director, Biomarker Sciences

Gilead

Bob Willette

Senior Fibrosis Advisor

ImmunoMet

Cory Hogaboam

Professor of Medicine & Adjunct Professor of Pathology

Cedars Sinai Medical Centre

Brian Yaspan

Senior Scientist

Genentech

Claude Jourdan Le Saux

Adjunct Associate Professor

UCSF

David Lagares

Assistant Professor of Medicine

Harvard Medical School

Jonathan Kropski

Assistant Professor

Vanderbilt University

Lee Borthwick

Senior Lecturer in Fibrosis Biology

Newcastle University

Maggie Neighbors

Senior Scientist

Genentech

Glenn Rosen

Senior Vice President, Pre-clinical Translational Sciences

Coherus Biosciences

Hans Brightbill

Senior Scientific Manager

Genentech

Harry Karmouty-Quintana

Assistant Professor

University of Texas Health Science Center at Houston

Mary Salvatore MD, MBA

Associate Professor of Radiology

Columbia University Medical Center

Peter Westenskow

Head of AI Section

Roche

Rick Jack

Senior Scientific Consultant

Promedior - a Member of the Roche Group

Sydney Montessi

Physician

Massachusetts General Hospital

Tama Evron

Associate Director Research & Evaluation Research

Corbus Pharmaceuticals

Toby Maher

Director, Interstitial Lung Disease Program

USC

Eric White

Director Clinical Development & Medical Affairs – IPF/ILD

Boehringer Ingelheim

James Trevaskis

Director, Fibrosis Biology, Research

Gilead

Jamie Bates

Director, Fibrosis

Gilead

Jeremy Duffield

Vice President

Vertex Pharmaceuticals

Johnathan Epstein

William Wikoff Smith Professor, Executive Vice Dean & Chief Scientific Officer

Perelman School of Medicine at the University of Pennsylvania

Karim Christian El Kasmi

Laboratory Head Immunology & Respiratory Macrophage Biology Innate Immunity

Boehringer Ingelheim

Ke Cheng

Co-founder

BreStem Therapeutics

Kevin Fowler

Principal

The Voice of the Patient

Rana Herro

Assistant Professor

Cincinnati Children’s Hospital

Rob Slack

Director of Pharmacology

Galecto

Rugmani Iyer

Senior Scientist II

Merck

Samir Ounzain

Chief Executive Officer & Scientific Co-Founder

HAYA Therapeutics

Scott MacDonnell

Associate Director Cardiovascular, Fibrosis, & Renal Research

Regeneron Pharmaceuticals

Sunhwa Kim

Principal Scientist

Merck

Wim van Schooten

Chief Scientific Officer

TeneoBio

Illan Yaron Director

Department of Medicine

Hadassah-Hebrew University Medical Center